That's right Craikey and it was only for a single preclinical asset targeting a single indication.
Remember Neuren's strategy: multiple therapeutic targets supported by the same investments, multiple potential outcomes at various stages, multiple paths to success. That's what get's me excited.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.79 |
Change
0.090(0.54%) |
Mkt cap ! $2.118B | |||
| Open | High | Low | Value | Volume |
| $16.68 | $16.86 | $16.51 | $2.310M | 138.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 100 | $16.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.79 | 54 | 3 |
View Market Depth
| Last trade - 13.36pm 30/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |